RIPK1 and glioblastoma: The TGCA data shown in Supplementary Fig. 6 confirm several studies which show increased expression of RIPK1, RIPK3, and MLKL in GBM compared to non-tumor tissue, as well as an unfavorable role for higher expression [48–50].